Spa Executive

OCTOBER 3, 2023

Before her time at Equinox, she served as the Global Director of Spa Development and Operations at Starwood Hotel & Resorts, managing the company’s spa brands, partnerships, and a global portfolio of over 450 spas. What industry trends or developments are you most excited about in 2023?

Portfolios 52

Portfolios Hospital Branding Innovations 52

Spa Executive

NOVEMBER 10, 2023

As global vice president of wellbeing, she will develop and deepen the wellness experience across Auberge Resorts Collection’s portfolio. I am particularly thrilled about reshaping the very concept of design-driven well-being within our global portfolio. I am truly delighted to join the portfolio at such an exhilarating juncture.

Portfolios 52

Portfolios Hospital Partnerships Branding 52

The Dermatology Digest

SEPTEMBER 30, 2024

market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. In February 2023, Fresenius Kabi and Formycon entered into a global commercialization partnership for the ustekinumab biosimilar candidate covering key global markets. and worldwide.

Portfolios 36

Portfolios Partnerships Marketing Safety 36

The Dermatology Digest

MARCH 27, 2024

Stern will join the global leadership team and will be responsible for leading the portfolio and brand strategies. Stern has taken over the role of Chief Marketing Officer from Can Gumus, who served from 2020 to 2023 before he was named President, Latin America (LATAM) Merz Aesthetics.

Office 36

Office Portfolios Branding Marketing 36

The Dermatology Digest

DECEMBER 19, 2023

FILSUVEZ joined the Chiesi portfolio as part of the agreement reached during the acquisition of Amryt Pharma in January 2023. Chiesi Global Rare Diseases’ FILSUVEZ is the first approved treatment for wounds associated with JEB, a rare, moderate-to-severe form of EB with blisters beginning in infancy.

Portfolios 36

Portfolios Management Clinic Treatments 36

Spa Executive

FEBRUARY 15, 2024

This means a guest staying at one hotel can visit a spa at another hotel in your company portfolio and charge the experience back to the room at the hotel where they are staying. This makes the guest’s experience more holistic and connected. We developed this to help our joint customers,” Purcell explains. “We

Hospital 52

Hospital Partnerships Management Portfolios 52

Skin Tour

MARCH 3, 2023

Allergan bought this product and added it to its portfolio a few years ago. It gets mixed with sterile water and often lidocaine (numbing) prior to injecting it because it ships in a vial in powder form. Why the change after 20 years? They commissioned some small studies to see if it would be safe to mix right as the patient arrives.

Injections 52

Injections Portfolios Clinic Sales 52

Spa Executive

JANUARY 16, 2024

Prior to stepping into this position in June 2023, Ms. Jumeirah’s spas all have a Middle Eastern influence which also underpins the signature brand experience across the portfolio. Design is a core focus for Jumeirah which also extends within the wellness spaces in the portfolio.

Hospital 52

Hospital Technology Branding Portfolios 52

The Dermatology Digest

DECEMBER 21, 2023

The two distribution agreements for the Evolysse /Estyme fillers portfolio will grant Evolus the ability to offer filler solutions to cover mid-face, nasolabial folds, and lip indications in Europe plus an eye product line in the U.S.

Marketing 36

Marketing Sales Branding Portfolios 36

The Dermatology Digest

DECEMBER 21, 2023

The two distribution agreements for the Evolysse /Estyme fillers portfolio will grant Evolus the ability to offer filler solutions to cover mid-face, nasolabial folds, and lip indications in Europe plus an eye product line in the U.S.

Marketing 36

Marketing Sales Branding Portfolios 36

Aesthetics Advisor

SEPTEMBER 15, 2023

This study is expected to wrap up by February 2023. For a full list of Marinomed’s portfolio of Carragelose® containing nasal sprays and oral products, please visit [link] , for a list of scientific publications on Carragelose®, [link]. Increasing clinical evidence indicates that Carragelose® can also inactivate SARS-CoV-2.[1],[2]

Hospital 69

Hospital Clinic Marketing Medical 69